[1] Michl J, Ingrouille M J, Simmonds M S, et al.Naturally occurring aristolochic acid analogues and their toxic-ities[J]. Nat Prod Rep, 2014,31(5):676-693. [2] Gokmen M R, Cosyns J P, Arlt V M, et al.The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review[J]. Ann Intern Med, 2013. 158(6): 469-477. [3] Balachandran P, Wei F, Lin R C, et al.Structure activity relationships of aristolochic acid analogues toxicity in cultured renal epithe-lial cells[J]. Kidney Int, 2005, 67(5): 1797-1805. [4] Chen D, Tang Z, Luo C, et al.Clinical and pathological spectrums of aristolochic acid nephropathy[J]. Clin Nephrol, 2012, 78(1): 54-60. [5] Mengs U.Acute toxicity of aristolochic acid in rodents[J]. Arch Toxicol, 1987, 59(5):328-331. [6] Zhao-Ning Lu, Qing Luo, Li-Nan Zhao, et al.The Mutational Features of Aristolochic Acid-Induced Mouse and Human Liver Cancers[J]. 2019, doi.org/10.1002/hep.30863. [7] 崔媛,李海山,宋乃宁,等. 马兜铃酸I影响小鼠肝脏脂肪酸β氧化和糖代谢以及TCA 循环的代谢组学研究.中国药物警戒, 2019,16(8):449-466. [8] Stiborova M, Frei E, Wiessler M, et al.Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids: evidence for reductive activation by cytochromes P450 1A1 and 1A2[J]. Chem Res Toxicol, 2001, 14(8): 1128-1137. [9] Stiborova M, Frei E, Hodek P, et al.Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH: cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer[J]. Int J Cancer, 2005, 113(2): 189-197. [10] Chan W, Cu L, Cai Z, et al.Study of the phaseⅠand phase II metabolism of nephrotoxin aristolochic acid by liquid chromatogra-phy/tandem mass spectrometry[J]. Rapid Commun Mass Spectrom, 2006, 20(11):1755-1760. [11] Martinez M C, Nortier J, Vanherweghem J L, et al.Progression rate of Chinese herb nephropathy:impact of Aristolochiafangchi ingested dose[J]. Nephrol Dial Tra-nsplant, 2002, 17(11): 408-412. [12] Faber M S, Jetter A, Fuhr U.Assessment of CYP1A2 activity in clinical practice: why,how,and when?[J]. Basic Clin Pharmacal Toxicol, 2005, 97(3):125-134. |